Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

A new review of clinical trial data finds evidence that GLP-1 drugs can meaningfully reduce dementia risk in people with type ...

Trial confirms that oral semaglutide lowers cardiovascular risk in type 2 diabetes, regardless of SGLT2i use. Read more!

Compounded semaglutide has not gone through the same review process as FDA-approved drugs, so it is unclear how safe or effective these products are. It’s important to get a prescription for ...

"But semaglutide isn't without side effects ... Steven Dayan, M.D., a plastic surgeon at Impressions Face + Body in Chicago ...

Research reveals GLP-1 receptor agonists influence gut microbiome, enhancing metabolic health and offering anti-inflammatory ...

To curb hunger and help achieve weight loss, some natural alternatives to Ozempic (semaglutide) may help. See what the ...

Scholar Rock Holding Corporation's apitegromab shows promise for SMA treatment, aims for 2025 launch. Click for my updated ...

As obesity rates rise among individuals with T1D, GLP-1 agonist medications, indicated for T2D and weight loss, are ...

Pfizer announced on Monday that it’s halting the development of its weight loss pill Danuglipron after a trial patient suffered a liver injury. According to a press […] ...